Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

German research bodies draft synthetic-biology plan

Three leading German research organizations have outlined how they think the country could play a major part in synthetic biology.

The DFG (which funds university research), the German Academy of Sciences Leopoldina and the German Academy of Science and Engineering argue in a 27 July report that synthetic biology has great value to society — as long as the field's expansion is balanced with ethical debate.

Germany is particularly sensitive to ethical issues in the life sciences, partly because of previous Nazi abuses of bioscience. The report says that a national centre should be created to host a database of information about newly created stretches of DNA, and to assess their safety.

Ralf Wagner, chief executive of Geneart, a leading manufacturer of synthetic genes based in Regensburg, Germany, says he hopes the report will help create a positive environment for public debate.

Additional information

For a longer version of this story, see

Rights and permissions

Reprints and Permissions

About this article

Cite this article

German research bodies draft synthetic-biology plan. Nature 460, 563 (2009).

Download citation


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing